Larvol Delta - Recent-Advances-in-the-Treatment-of-Prostate-Cancer--Episode-9-Selecting-Optimal-Therapy-for-mHSPC-Design-of-the-ARASENS-Trial

Nubeqa (darolutamide) - Bayer, Orion Corp

Yonsa (abiraterone acetate) - Churchill Pharma, Sun Pharma

https://www.onclive.com/view/selecting-optimal-therapy-for-mhspc-design-of-the-arasens-trial

Apr 27, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next